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Purpose: An elevated bilirubin concentration can interfere with the spectrophotometric 
measurement of various analyses, and sometimes directly interacts with the chemical 
reaction. A change in our chemistry workstation Roche® Modular P-module occurred 
recently; before introducing the new methods, we aimed at defining for all tests 
measured by spectrophotometry the bilirubin concentration above which the validation 
program automatically replaces the numerical result by the comment “icteric sample”. 
These limits were compared with the values recommended by Roche®. 
 
Method: Using Roche5 Modular P900-module, we measured in duplicate 30 routine 
biochemical tests on 4 serum pools characterized by a low concentration of bilirubin (<3 
mg/l). Aliquots of these pools were spiked with increasing volumes of a fresh bilirubin 
solution (approximately 3000 mg/l). The maximal bilirubin level in the spiked samples 
was about 300 mg/l (30 mg/dl), a concentration rarely observed in clinical practice. The 
mean changes in concentrations of the 30 tests in the aliquots of the four pools were 
analyzed in relation to bilirubin concentrations. Variations higher or lower than 10% 
from the initial values were considered as unacceptable interferences. As NaOH 0.1 M 
was used to solubilize bilirubin, we also evaluated the influence of small pH variations, 
by measuring serum pool with the same concentrations of NaOH but without addition of 
bilirubin. 
For all tests, measurements on aliquots containing NaOH were not influenced. 
 
Results: Bilirubin causes no or little variations (<10%) on the different tests except the 
following analyses: 
—Total cholesterol: 10% decrease at 130 mg/l bilirubin (Roche® value: 
100 mg/l) 
—Triglycerides: 10% increase at24omg/l bilirubin(Roche®value: 27Omg/l) 
— Magnesium: 10% increase at2bo mg/l bilirubin (Roche5’value: 370mg/l) 
—Total proteins: 10% decrease at 250 mg/l bilirubin (Roche® value: 
250 mg/l) 
 
Conclusions: Most of the tests are not significantly influenced by hyperbilirubinemia, 
except the following analyses: magnesium, total cholesterol, total proteins, and 
triglycerides. 
In practice, our results were in agreement with thresholds announced by Roche®. 
However, differences were recorded for magnesium that we found lower (250 mg/l vs 
370 mg/l), total cholesterol slightly higher 130 mg/l vs 100 mg/l) and triglycerides 
lower (240 mg/l vs 270 mg/l). 
